Economic ConditionsThere is caution due to continued economic weakness in China and the possibility of tariff wars, which could impact the business negatively.
Regulatory ChallengesUncertainty exists due to important regulatory and commercial hurdles for the PRP programme, affecting near-term confidence.
Stock ValuationThe company's shares trade at premium multiples compared to peers, despite having similar growth rates and lower margins.